The Venture Codex Logo

The Venture Codex

RWDC Industries

190 Woodlands Industrial Park E5, #10-06 Woodlands Bizhub, Singapore, 757516

Overview

RWDC Industries develops cost-effective biopolymer material solutions, principally polyhydroxyalkanoate (PHA), which is fully biodegradable and intended as a substitute for single-use plastics. Its PHA can replace conventional plastics in items such as straws, utensils, cups, plates and lids. The company emphasizes sustainable practices and supports responsible plastic waste management, including recycling. RWDC was co-founded by Dr. Daniel Carraway and Roland Wee and was founded in 2015. The firm closed a US$133M two-stage Series B to expand operations. Proceeds will be used to increase production capacity, including a new facility in Athens, Georgia. RWDC Industries develops medium-chain-length polyhydroxyalkanoate (mcl-PHA) biopolymers produced by bacterial fermentation of plant-based oils or sugar. Its PHA is certified by TÜV Austria to be fully biodegradable in soil, water and marine conditions, degrading within weeks with no toxic residue. The company positions PHA as a commercially viable biodegradable bioplastic for a broad range of applications and has completed client trials on PHA straws and coated paper. RWDC has initiated development programs on new applications such as non-woven fabrics and expanded production capacity in Athens, Georgia. It expects its first commercial batch of PHA straws to be available in 2019. RWDC was founded in 2015 by Roland Wee and Dr Daniel Carraway and is based in Singapore. The company recently raised financing to support capacity expansion and R&D. RWDC Industries is a Singapore-headquartered biotech startup that develops and produces commercially biodegradable bioplastic. The company focuses on creating commercially viable biodegradable bioplastic products for the market. According to the article, RWDC raised $12 million in a Series A2 funding round. The round was co-anchored by venture capital firms Vickers Venture Partners and WI Harper Group. The article does not provide additional operating metrics, revenue, or detailed future plans.

Total raised
$168M
Funding rounds
3
Latest round
Series B
Latest activity
May 2020

Industries

  • Advanced Materials
  • Biotechnology
  • Manufacturing
  • Plastics and Rubber Manufacturing
Visit website

Recent funding

  1. Series B

    May 2020

    $133M

  2. Series A

    Apr 2019

    $22M

  3. Series A

    Oct 2018

    $13M

Team

  • Dr. Daniel Carraway

    Co-Founder & Chief Executive Officer

  • Roland Wee

    Co-Founder & Executive Chairman

  • Thomas Aebischer

    CFO

    LinkedIn
  • Dennis Sewell

    Quality Assurance Manager

    LinkedIn